Gara Jalqabaatti › Obesity › Texas › Austin
Qorannoo klinikaalii Obesity Austin, TX keessatti
Qorannoo 20 Obesity f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Elligo Clinical Research Center, Austin
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Elligo Clinical Research Center /ID# 282166, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Namoota walitti qabaa jiraSadarkaa 3
- Texas Diabetes & Endocrinology, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Namoota walitti qabaa jiraSadarkaa 3
- Dell Children's Medical Center - PIN, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- IMA Clinical Research Austin, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- FutureSearch Trials of Neurology, Austin
Semaglutide for Post-Smoking Cessation Weight Management
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Austin Heart, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
- ACCOMPLISH-2 Research Site, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- IMA Clinical Research Austin, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Austin Heart, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Namoota walitti qabaa jiraSadarkaa 1
- Elligo Clin Res Centre, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Namoota walitti qabaa jiraSadarkaa 1
- Corxel Investigational Site, Austin
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Dell Pediatric Research Center, Austin
- University of Texas at Austin, Austin
Qorannoo Obesity magaalota biroo keessatti
- Houston, TXQorannoo 43
- Chicago, ILQorannoo 41
- New York City, NYQorannoo 40
- San Antonio, TXQorannoo 40
- Washington, DCQorannoo 33
- Orlando, FLQorannoo 32
- Dallas, TXQorannoo 30
- Boston, MAQorannoo 28
- Las Vegas, NVQorannoo 27
- Miami, FLQorannoo 27
- Baltimore, MDQorannoo 26
- Jacksonville, FLQorannoo 25
Qorannoo biroo Austin keessatti
- Kansara Qara'a Non-Small CellQorannoo 30
- Saree (Gosoota Hunda)Qorannoo 20
- Kansarii ColorectalQorannoo 19
- Kansara MetastatikiiQorannoo 19
- Baayyee UlfaataaQorannoo 18
- Cufama OnneeQorannoo 18
- Saree OljooQorannoo 18
- Kansarii OvariiQorannoo 17
- Kansa EndometiriyaaliiQorannoo 15
- Kansarii ProstateQorannoo 15
- DepreshiniiQorannoo 14
- SchizophreniaQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.